--- title: "Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Atkore Inc. (ATKR) and Encourages Shareholders to Learn More About the Investigation" description: "Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against Atkore Inc. (ATKR) for corporate wrongdoing. The investigation targets investors who purchased Atkore securities before Aug" type: "news" locale: "en" url: "https://longbridge.com/en/news/251341856.md" published_at: "2025-08-03T14:00:01.000Z" --- # Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Atkore Inc. (ATKR) and Encourages Shareholders to Learn More About the Investigation > Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against Atkore Inc. (ATKR) for corporate wrongdoing. The investigation targets investors who purchased Atkore securities before August 2, 2022. Shareholders are encouraged to visit bgandg.com/ATKR for more information and to assist in the investigation. The firm operates on a contingency fee basis, meaning they only charge if successful in recovering funds for investors. Bronstein, Gewirtz & Grossman is known for representing investors in securities fraud class actions. NEW YORK CITY, NY / ACCESS Newswire / August 3, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Atkore Inc. ("Atkore" or "the Company") . Investors who purchased Atkore securities prior to August 2, 2022, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/ATKR. **Investigation Details** The investigation concerns whether Atkore and certain of its officers and/or directors have engaged in corporate wrongdoing. **What's Next?** If you are aware of any facts relating to this investigation or purchased Atkore shares, you can assist this investigation by visiting the firm's site: bgandg.com/ATKR. You can also contact Peretz Bronstein or his client relations manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC: **There is No Cost to You** We represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys' fees, usually a percentage of the total recovery, only if we are successful. **Why Bronstein, Gewirtz & Grossman** Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide. Follow us for updates on LinkedIn, X, Facebook, or Instagram. Attorney advertising. Prior results do not guarantee similar outcomes. **Contact** **SOURCE:** Bronstein, Gewirtz & Grossman, LLC View the original press release on ACCESS Newswire ### Related Stocks - [ATKR.US - Atkore](https://longbridge.com/en/quote/ATKR.US.md) ## Related News & Research | Title | Description | URL | |-------|-------------|-----| | A Look at Atkore's Upcoming Earnings Report | Atkore (NYSE:ATKR) will release its quarterly earnings report on February 3, 2026, with analysts estimating an EPS of $0 | [Link](https://longbridge.com/en/news/274543538.md) | | Atkore Inc. hielt Hauptversammlung ab | Atkore Inc. held its annual general meeting on January 29, 2026, where several proposals were approved, including the el | [Link](https://longbridge.com/en/news/274564966.md) | | Atkore Inc. Executives to Join Citi's Global Industrial Tech and Mobility Conference | Atkore Inc. will participate in Citi's Global Industrial Tech and Mobility Conference on February 18, 2026, in Miami, wi | [Link](https://longbridge.com/en/news/275305063.md) | | Atkore (ATKR) Is Up 8.7% After Announcing Strategic Review Committee and Board Expansion | Atkore Inc. announced a cooperation agreement with Irenic Capital Management, leading to board expansion and the formati | [Link](https://longbridge.com/en/news/267930999.md) | | Atkore Q1 net sales slightly beat analyst expectations | Atkore's fiscal Q1 net sales slightly exceeded analyst expectations at $655.55 million. However, adjusted EBITDA decreas | [Link](https://longbridge.com/en/news/274643802.md) | --- > **Disclaimer**: This article is for reference only and does not constitute any investment advice.